Title : Comparative Bioavailability study of a Novel Multi-day Patch Formulation of Rivastigmine (twice weekly) with Exelon Transdermal Patch (daily). A randomized clinical trial - Schurad_2022_Curr.Alzheimer.Res__ |
Author(s) : Schurad B , Koch C , Schug B , Morte A , Vaque A , de la Torre R , Iniesta M |
Ref : Curr Alzheimer Res , : , 2022 |
Abstract : Schurad_2022_Curr.Alzheimer.Res__ |
ESTHER : Schurad_2022_Curr.Alzheimer.Res__ |
PubMedSearch : Schurad_2022_Curr.Alzheimer.Res__ |
PubMedID: 36017827 |
Schurad B, Koch C, Schug B, Morte A, Vaque A, de la Torre R, Iniesta M (2022)
Comparative Bioavailability study of a Novel Multi-day Patch Formulation of Rivastigmine (twice weekly) with Exelon Transdermal Patch (daily). A randomized clinical trial
Curr Alzheimer Res
:
Schurad B, Koch C, Schug B, Morte A, Vaque A, de la Torre R, Iniesta M (2022)
Curr Alzheimer Res
: